FDA Round Up – Q1 2024
FDA ROUNDUP: FDA Urges Sponsors to Conduct Third Party [...]
FDA Round Up – Q4 2023
FDA ROUNDUP: New FDA guidance: Stimulant Use Disorders: Developing [...]
FDA Round Up – Q3 2023
FDA ROUNDUP: FDA Issues New User Fees for 2023-2024 [...]
FDA Round Up – Q2 2023
FDA ROUNDUP: FDA issues important draft guidance for developers [...]
FDA Round Up – Q1 2023
FDA ROUNDUP: Rare Disease Day: On February 27, 2023, [...]
gET sOCIAL